KPMG: Tailwinds and Headwinds for Payers in 2024
A recent KPMG report laid out several tailwinds and headwinds for payers in 2024. Payers' tailwinds include reduced recession worries, while their headwinds include Medicare Advantage scrutiny.
presented by
Healthcare M&A Activity Reaches 3-Year Low, But It Might Pick Up in the Back Half of ‘23
M&A activity in the healthcare sector continued to decline in the second quarter of 2023, with the number of deals reaching its lowest point in three years. However, a new report predicted that M&A activity could increase in the second half of this year due to healthcare companies’ continually shrinking valuations and their divestitures of non-core assets.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Is Exiting the Employer Insurance Market a Smart Move for Humana?
Over the next 18 to 24 months, Humana will exit the Employer Group Commercial Medical Products business, which includes fully insured plans, self-funded plans and Federal Employee Health Benefit plans. The decision represents Humana's move to double-down on its Medicare Advantage business, one expert said.
3 Healthcare Macroeconomic Trends a KPMG Exec Will Follow in 2023
As the healthcare industry prepares for a possible recession, Ash Shehata of KPMG expects to see more use of technology, targeted investments and an impact on consumers' wallets.
Merck, IBM, Walmart and KPMG to pilot blockchain pharmaceutical supply chain system
The four companies are collaborating under a program that stems from a law that Congress passed in 2013 to develop an electronic pharmaceutical tracking system.
KPMG survey: Data aggregation continues to pose challenge for population health ambitions
“The complaints about incorporating technology into clinical workflows are fairly common and have many doctors and others involved with care delivery dissatisfied with electronic health records and other tools,” said Todd Ellis, principal at KPMG.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.